Kosh Agarwal - Publications, H-index & Citations

Kosh Agarwal

University of London

60H指数

625论文数

2.3W被引数

收录论文 256

发表时间

siRNA daplusiran/tomligisiran and DNA vaccine JNJ-64300535 in NA-suppressed chronic hepatitis B: the OSPREY study

npj Vaccines

IF6.5

2026-08-31

OAAI

Stefan Bourgeois; Maria Buti; Edward J. Gane; Kosh Agarwal; Ewa Janczewska; Yao-Chun Hsu; Maurizia Rosanna Brunetto; Pietro Lampertico; Joaquin Cabezas; Gloria Kim; Leen Slaets; Adam Bakala; Heather L. Davis; Dessislava Dimitrova; Joris Vandenbossche; Bart Fevery; Ewoud De Troyer; Alan Harrison; Pieter Van Remoortere; Marjolein Crabbe; Simon Verheijden; An De Creus; Michael Biermer

Therapeutic vaccination strategy targeting the PreS1 region of L-HBsAg for HBV/HDV co-infection 针对L-HBsAg PreS1区域的HBV/HDV共感染治疗性疫苗接种策略

JHEP Reports

IF7.5

2026-08-17

OAAI

Rebecca A. Russell; James Lok; James M. Harris; Senko Tsukuda; Louisa M. Rose; Bethany G. Charlton; Ivana Carey; Kosh Agarwal; Peter A.C. Wing; Sumi Biswas; Jane A. McKeating; Matthew D.J. Dicks

Safety, Tolerability, and Pharmacodynamics of GS-4224 in Healthy Participants and Participants With Chronic Hepatitis B GS-4224在健康受试者和慢性乙型肝炎患者中的安全性、耐受性和药效学研究

Liver International

IF5.2

2026-05-21

PREAI

Edward J. Gane; Chi-Yi Chen; Cheng-Hao Tseng; Chun-Yen Lin; Stuart K. Roberts; Dana Tedesco; Frida Abramov; Fangqiu Zhang; Jared M. Odegard; Jeffrey J. Wallin; Naveed A. Shaik; Teri Chew; Latesh Lad; Adele Y. Wang; Scott Balsitis; Simon P. Fletcher; Audrey H. Lau; Wan-Long Chuang; Kosh Agarwal

What is the emerging role of RNA interference in HBV cure strategies?RNA干扰在乙型肝炎病毒治愈策略中的新兴作用是什么？

Expert Opinion on Pharmacotherapy

IF2.7

2026-05-01

PREAI

Cargill, Zillah; Agarwal, Kosh

Setting the Record Straight: Utility and Outcomes in Patients With HCV Related HCC 澄清记录：丙型肝炎病毒相关肝细胞癌患者的疗效与结局

Journal of Viral Hepatitis

IF2.3

2026-03-01

PREAI

Guerra-Veloz, Maria Fernanda; Shah, Sital; Emmanouil, Beatrice; Olsen, Mia; George, Renita; Selemani, Sarah; Ross, Paul J.; Carey, Ivana; Mehta, Neha; Gillyon-Powell, Mark; Agarwal, Kosh

Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion report 布卢韦尔蒂德治疗慢性丁型肝炎：从临床试验到真实世界数据：专家意见报告

Antiviral Research

IF4

2025-11-19

PREAI

Tarik Asselah; Homie Razavi; Hélène Fontaine; Kosh Agarwal

A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2025-11-01

PREAI

Asselah, Tarik; Chattergoon, Michael A.; Jucov, Alina; Streinu-Cercel, Anca; Lampertico, Pietro; Wedemeyer, Heiner; Kennedy, Patrick T.; Gane, Edward J.; Bullard, Brianna L.; Chow, Sophia; Santos, Desiree; Camus, Gregory; Lu, Yimeng; Pilowa, Cara; Hwang, Carey; Correll, Todd; Agarwal, Kosh

Viral sequence analysis of chronic hepatitis B patients treated with the siRNA JNJ-73763989 in phase 2 clinical trials 接受siRNA JNJ-73763989治疗的慢性乙型肝炎患者病毒序列分析：II期临床试验

JHEP Reports

IF7.5

2025-10-09

OAAI

Thierry Verbinnen; Erkki Lathouwers; John Jezorwski; Michael Biermer; Ilse Augustyns; Craig Grant; Kosh Agarwal; Man-Fung Yuen; Sandra De Meyer; Oliver Lenz

Association between sustained virological response and adverse liver-related events in patients with decompensated HCV cirrhosis 持续病毒学应答与失代偿期HCV肝硬化患者不良肝脏相关事件之间的关联

Clinical Gastroenterology and Hepatology

IF12

2025-09-15

PREAI

Lisa M. van Velsen; Lisette A.P. Krassenburg; Grishma Hirode; Kosh Agarwal; Graham R. Foster; Zillah Cargill; Raoel Maan; Michael P. Manns; Heiner Wedemeyer; Markus Cornberg; Robert J. de Knegt; Gonzalo Crespo; Jose L. Calleja; Alnoor Ramji; Giuseppina Brancaccio; Maria Cristina Morelli; Ilaria Lenci; Chiara Mazzarelli; Raffaella Vigano; Paolo Angeli; Patrizia Burra; Maria Francesca Donato; Paola Carrai; Silvia Martini; Paolo Caraceni; Francesco Paolo Russo; Harry L.A. Janssen; Bettina E. Hansen; Adriaan J. van der Meer; Jordan J. Feld; Milan J. Sonneveld

Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease 代谢功能障碍或有代谢功能障碍相关脂肪性肝病的慢性乙型肝炎患者中，肝细胞癌及其他肝脏相关事件的预测

Alimentary Pharmacology & Therapeutics

IF6.7

2025-09-09

OAAI

Lesley A. Patmore; Ivana Carey; Jordan J. Feld; Willem P. Brouwer; Keyur Patel; Maria Buti; Pieter Honkoop; Douwe F. Postma; Hans Blokzijl; Özgur. M. Koc; Eva van Oorschot; Kosh Agarwal; Marc van der Valk; Faydra I. Lieveld; Mai Kilany; Matthijs Kramer; Joep de Bruijne; Mark A. A. Claassen; Bettina E. Hansen; Robert A. de Man; Harry L. A. Janssen; R. Bart Takkenberg; Milan J. Sonneveld

Evaluation of Hepatitis B core related antigen (HBcrAg) as a biomarker in cohorts from the United Kingdom and South Africa 评估乙型肝炎核心相关抗原（HBcrAg）作为生物标志物在英国和南非队列中的应用

Journal of Infection

IF11.9

2025-08-21

OAAI

Louise O. Downs; Marion Delphin; Marije van Schalkwyk; Susan Hugo; Sheila F. Lumley; Elizabeth Waddilove; Tingyan Wang; Jacqueline Martin; Catherine de Lara; Arran Babbs; Monique I. Andersson; Richard H. Glashoff; M. Azim Ansari; Kosh Agarwal; Geoffrey Dusheiko; Jantjie Taljaard; Wolfgang Preiser; Eleanor Barnes; Gavin Kelly; Ivana Carey; Yusuke Shimakawa; Tongai G. Maponga; Philippa C. Matthews

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B

HEPATOLOGY COMMUNICATIONS

IF4.6

2025-03-01

PREAI

van Boemmel, Florian; Verbinnen, Thierry; Agarwal, Kosh; Vanwolleghem, Thomas; Lampertico, Pietro; Buti, Maria; Janczewska, Ewa; Bourliere, Marc; Jezorwski, John; Donohue, Kathleen; Kim, Gloria; Kakuda, Thomas N.; De Meyer, Sandra; Bakala, Adam; Biermer, Michael; Lenz, Oliver

Unlocking hope: HCV re-treatment strategy for patients with active hepatocellular carcinoma

JHEP REPORTS

IF7.5

2024-11-01

PREAI

Shah, Sital; Veloz, Maria Fernanda Guerra; Agarwal, Kosh; Cannon, Mary

Predictive performance of hepatocellular carcinoma risk scores in chronic hepatitis C patients with advanced fibrosis after achieving sustained virological response: Insights from European Association for the study of the Liver Policy recommendations

EUROPEAN JOURNAL OF INTERNAL MEDICINE

IF6.1

2024-11-01

PREAI

Soliman, Riham; Lok, James; Ajaz, Saima; Agarwal, Kosh; Guerra, Maria

microRNA associated with hepatocyte injury and systemic inflammation may predict adverse outcomes in cirrhotic patients

SCIENTIFIC REPORTS

IF3.9

2024-10-11

OAAI

Tavabie, Oliver D.; Patel, Vishal C.; Salehi, Siamak; Stamouli, Marilena; Trovato, Francesca M.; Maxan, Maria-Emanuela; Jeyanesan, Dhaarica; Rivera, Savannah; Mujib, Salma; Zamalloa, Ane; Corcoran, Eleanor; Menon, Krishna; Prachalias, Andreas; Heneghan, Michael A.; Agarwal, Kosh; Mcphail, Mark J. W.; Aluvihare, Varuna R.

Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2024-09-27

OAAI

Buti, Maria; Lim, Young-Suk; Chan, Henry Lik Yuen; Agarwal, Kosh; Marcellin, Patrick; Brunetto, Maurizia R.; Chuang, Wan-Long; Janssen, Harry L. A.; Fung, Scott K.; Izumi, Namiki; Jablkowski, Maciej S.; Abdurakhmanov, Dzhamal; Abramov, Frida; Wang, Hongyuan; Botros, Irina; Yee, Leland J.; Mateo, Roberto; Flaherty, John F.; Osinusi, Anu; Pan, Calvin Q.; Shalimar, X.; Seto, Wai-Kay; Gane, Edward J.

JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2

JOURNAL OF HEPATOLOGY

IF33

2024-09-01

OAAI

Agarwal, Kosh; Buti, Maria; van Boemmel, Florian; Lampertico, Pietro; Janczewska, Ewa; Bourliere, Marc; Vanwolleghem, Thomas; Lenz, Oliver; Verbinnen, Thierry; Kakuda, Thomas N.; Mayer, Cristiana; Jezorwski, John; Muenz, Daniel; Beumont, Maria; Kalmeijer, Ronald; Biermer, Michael; Lonjon-Domanec, Isabelle

Switching to tenofovir alafenamide in patients with virologically suppressed chronic hepatitis B and renal or hepatic impairment: final week 96 results from an open-label, multicentre, phase 2 study 切换到替诺福韦alafenamide患者病毒学抑制慢性乙型肝炎和肾或肝损害: 最后一周96结果从开放标签，多中心，2期研究

LANCET GASTROENTEROLOGY & HEPATOLOGY

IF38.6

2024-08-01

PREAI

Janssen, Harry L. A.; Lim, Young-Suk; Lampertico, Pietro; Heo, Jeong; Chen, Chi-Yi; Fournier, Claire; Tsang, Tak Yin Owen; Bae, Ho; Chen, Chien-Hung; Coffin, Carla S.; Ahn, Sang Hoon; Trinh, Huy; Flaherty, John F.; Abramov, Frida; Zhao, Yang; Liu, Yang; Lau, Audrey; German, Polina; Chuang, Wan-Long; Agarwal, Kosh; Gane, Edward

Lack of awareness and ethnic polarity is a major cause of metabolic associated fatty liver disease in high-risk diabetes population in South London

therapeutic advances in musculoskeletal disease

IF2.8

2024-07-30

OAAI

Ajaz, Saima; Chamley, Mark; Lok, James; Soliman, Riham; Khan, Reece; Ahir, Karan; Curtis, Monique; Guerra-Veloz, Maria Fernanda; Agarwal, Kosh

Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses

JHEP REPORTS

IF7.5

2024-04-01

OAAI

Yuen, Man-Fung; Fung, Scott; Ma, Xiaoli; Nguyen, Tuan T.; Hassanein, Tarek; Hann, Hie -Won; Elkhashab, Magdy; Nahass, Ronald G.; Park, James S.; Jacobson, Ira M.; Ayoub, Walid S.; Han, Steven -Huy; Gane, Edward J.; Zomorodi, Katie; Yan, Ran; Ma, Julie; Knox, Steven J.; Stamm, Luisa M.; Bonacini, Maurizio; Weilert, Frank; Ramji, Alnoor; Bennett, Michael; Ravendhran, Natarajan; Chan, Sing; Dieterich, Douglas T.; Kwo, Paul Yien; Schiff, Eugene R.; Bae, Ho S.; Lalezari, Jacob; Agarwal, Kosh; Sulkowski, Mark S.

研究方向